01 6Janumet
02 10Januvia
03 1Sujanu
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 3,306
2019 Revenue in Millions : 3,482
Growth (%) : -5
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,971
2019 Revenue in Millions : 2,041
Growth (%) : -3
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 1,964
2020 Revenue in Millions : 1,971
Growth (%) : 0
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 3,324
2020 Revenue in Millions : 3,306
Growth (%) : 1
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 94
2021 Revenue in Millions : 106
Growth (%) : -10
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 1,700
2021 Revenue in Millions : 1,964
Growth (%) : -13
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 2,813
2021 Revenue in Millions : 3,324
Growth (%) : -15
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 1,177
2022 Revenue in Millions : 1,700
Growth (%) : -31
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 2,189
2022 Revenue in Millions : 2,813
Growth (%) : -22
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 3,931
2014 Revenue in Millions : 3,863
Growth (%) : -2%
LOOKING FOR A SUPPLIER?